Ann: First-in-human clinical trials begin in Singapore, page-3

Its sad how the armchair commentators flooded in and had to sow FUD. This company has been a mess of capital mismanagement and corporate action disarray for all to see, but the trolls have to chime in. Some of those poor souls who sold down to $0.05 probably did so listening to the commentary on these threads.

This company is not quite dead in the water yet and recently pulled a couple of Singaporean and Vietnamese rabbits out of the hat. The A*star research collaboration was always a big deal, that so many investors seemed to have forgotten, as indicated by the trading:

https://www.a-star.edu.sg/simtech/news-events/industry-updates/industry_updates/updates/ASTAR_collaborate_Osteopore_NDCS#:~:text=A*STAR%20is%20pleased%20to,improve%20clinical%20outcomes%20to%20patients.